drugset / Trial / NCT03736629

Azithromycin Treatment for the Airway Microbiome in Asthma

NCT03736629

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study to determine whether the bacteria inside the lungs of people with asthma can be modified (changed) if they are given an antibiotic and if this change is associated with an improvement in asthma symptoms.

Timeline

Start
2019-02-01
Primary completion
2021-03-01
Completion
2022-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 250 mg Oral

Indications